Rezzayo approved to treat adult patients with invasive candidiasis

HM Government

Twitter

Facebook

email

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (29 January 2024) approved the medicine Rezzayo (rezafungin) to treat a fungal infection called invasive candidiasis.

Follow this news feed:

Guidance: Check import risk categories and related rules for animals and animal products imported from the EU to Great Britain, from 31 January 2024 We urge the Sudanese authorities and all relevant parties to cooperate fully with the ICC: UK statement at the UN Security Council

Leave a Reply Cancel reply